Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

OVCON-35 Drug Profile

« Back to Dashboard
Ovcon-35 is a drug marketed by Warner Chilcott Llc and Warner Chilcott and is included in two NDAs.

The generic ingredient in OVCON-35 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

Summary for Tradename: OVCON-35

Drug Prices: :see details

Clinical Trials for: OVCON-35

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Warner Chilcott Llc
ethinyl estradiol; norethindrone
TABLET;ORAL-28017716-001Approved Prior to Jan 1, 1982DISCNNo
Warner Chilcott
ethinyl estradiol; norethindrone
TABLET;ORAL-21018127-001Approved Prior to Jan 1, 1982DISCNNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: OVCON-35

Drugname Dosage Strength RLD Submissiondate
norethindrone and ethinyl estradiol and ferrous fumarateChewable Tablets0.4 mg/0.035 mgOvcon-35 Fe4/27/2007
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.